IDEX Corporation

IDEX Corporation (IEX) Market Cap

IDEX Corporation has a market capitalization of $16.99B.

Price: $230.45

-3.32 (-1.42%)

Market Cap: 16.99B

NYSE · time unavailable

CEO: Eric D. Ashleman

Sector: Industrials

Industry: Industrial - Machinery

IPO Date: 1989-06-02

Website: https://www.idexcorp.com

IDEX Corporation (IEX) - Company Information

Market Cap: 16.99B|Sector: Industrials

Company Profile

IDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications. This includes advanced fluidic devices, various types of pumps (rotary lobe, centrifugal, positive displacement), roll compaction and drying technologies, pneumatic components, and sealing solutions, as well as biocompatible medical devices, optical components, and precision photonic solutions. Key markets for this segment encompass food and beverage, pharmaceutical, cosmetics, marine, chemical, wastewater treatment, life sciences, research, and defense. Finally, the FSDP segment delivers critical equipment for emergency services, such as firefighting pumps, valves, rescue tools, and lifting bags. It also provides engineered stainless steel banding and clamping devices for industrial and commercial use, alongside specialized precision equipment for dispensing, metering, and mixing colorants and paints for retail and commercial clients. IDEX Corporation was founded in 1987 and maintains its headquarters in Northbrook, Illinois.

Analyst Sentiment

69%
Buy

From 15 Active Polls

1Y Forecast: $250.71

▲ +8.8% Potential Upside

Consensus Target Metrics

Low Bound

$214

Median

$257

High Bound

$268

Average

$251

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$250.71
▲ +8.79% Upside
Low Target
$214.00
-7% Risk
Median Target
$257.00
12% Mid
High Target
$268.00
16% Max
Consensus
Hold
14 / 29 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)16,98916,79414,08413,31012,22313,27313,69915,86416,238
Enterprise Value ($M)18,22618,03215,39714,57913,55914,58015,07217,23017,707
Price to Earnings Ratio (P/E)33.0629.2529.4325.8623.9425.2335.9132.3034.16
Price/Earnings-to-Growth Ratio (PEG)7.7011.1415.574.023.98
Price to Sales Ratio (P/S)4.7418.2415.8814.8013.9115.3416.8218.3820.34
Price to Book Ratio (P/B)4.254.193.483.303.053.313.514.184.25
Price to Free Cash Flow Ratio (P/FCF)26.4894.88163.7670.1364.7890.35149.88100.9884.75
Enterprise Value to Sales (EV/Sales)19.5917.3616.2115.4316.8518.5119.9722.18
Enterprise Value to EBITDA (EV/EBITDA)20.1589.6267.9261.4156.7161.6579.1278.8284.88
Debt to Equity Ratio1.370.460.470.460.480.470.500.520.55

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 IDEX CORP (IEX) — Investment Overview

🧩 Business Model Overview

IDEX CORP operates as a diversified industrial technology company across engineered components and systems used in safety-critical and process-intensive applications. The company typically participates in two connected parts of the value chain: (1) design/engineering and qualification of components into customer equipment (often under long acceptance cycles), and (2) supply of installed-base replenishment and aftermarket needs (filters, valves, pumps, metering parts, and related consumables depending on the platform).

A common business pattern across segments is “design-in” engineering: IDEX’s products are selected for specific performance requirements (accuracy, reliability, pressure/flow boundaries, chemical compatibility, safety compliance), which then creates an installed base that drives ongoing replacement and service demand. This structure reduces the likelihood of pure commodity price competition and supports a more durable order-to-customer relationship than standard industrial hardware.

💰 Revenue Streams & Monetisation Model

Revenue monetisation is driven by a blend of project/system sales and recurring aftermarket usage. While individual contracts can be transactional, many of IDEX’s product categories exhibit repeat buying dynamics due to replacement intervals, spares, and “same-platform” upgrades inside customer equipment.

Margin drivers generally include:

  • Engineering content and application specificity: engineered pumps, valves, and components priced for performance outcomes rather than commodity specs.
  • Installed-base economics: aftermarket parts tend to be less cyclical than the initial equipment spend and can sustain gross margin through mix.
  • Operational leverage: manufacturing scale in niche platforms and cost discipline that supports profitability across industrial cycles.

🧠 Competitive Advantages & Market Positioning

IDEX’s core moat is primarily high switching costs combined with process/qualification barriers. Competitors can offer alternatives, but replacing qualified components in safety-relevant systems or precision dosing applications often involves re-validation, redesign, and downtime costs. This “re-design friction” supports customer stickiness once IDEX products are embedded.

The company also benefits from intangible assets in the form of product know-how, application engineering, and compliance-related manufacturing discipline. These assets raise the practical barrier to entry for new entrants attempting to match reliability, materials compatibility, and long-term performance.

  • Switching-cost moat: design-in qualification, ongoing compatibility requirements, and spare-part continuity.
  • Reliability and safety qualification: performance verification and compliance expectations that favor established suppliers.
  • Portfolio diversification: exposure to multiple niche end markets rather than a single industrial cycle.

Competitive benchmarking (examples):

  • Graco (fluid handling and metering systems): focuses heavily on industrial fluid transfer and precision dosing. IDEX often competes more in specialized platforms with deeper niche customization and installed-base-driven replenishment patterns across multiple end markets.
  • Parker Hannifin (industrial motion and fluid power): broad portfolio and scale. IDEX’s positioning tends to emphasize application-specific engineered components and qualification dynamics that can make procurement choices less “catalog-driven.”
  • Johnson Controls (fire and building technologies): strong position in fire detection/control ecosystems. IDEX’s focus includes engineered fire-safety components and systems where performance qualification and reliability expectations create supplier continuity.

Overall, IDEX’s strategy contrasts with broader diversified industrial peers by leaning into engineered niches where performance qualification and compatibility requirements materially affect customer switching behavior.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand trends that increase the need for precision, reliability, and safety compliance:

  • Process intensification and automation: greater deployment of automated dosing, fluid handling, and control systems in industrial production increases demand for accurate metering and durable components.
  • Biopharma and life-science expansion: scaling of biologics manufacturing and laboratory workflows supports continued procurement of precision fluid systems and compatible components.
  • Safety and regulatory compliance tailwinds: fire-safety adoption and reinforcement in commercial and industrial facilities supports recurring replacement and upgrade cycles.
  • Energy-efficiency and reliability-driven upgrades: customers increasingly prioritize operational uptime and maintenance predictability, benefiting suppliers with proven reliability and service parts.

TAM expansion is less about broad “market share fights” and more about embedding IDEX deeper into customer equipment architectures where qualification cycles and long asset lifetimes create durable replacement demand.

⚠ Risk Factors to Monitor

  • Industrial end-market cyclicality: parts of the portfolio tied to capital equipment spending can face downturn pressure if customer budgets tighten.
  • Qualification and program risk: new platform wins require engineering execution; delays or specification mismatches can slow design-in adoption.
  • Competitive pricing pressure: established competitors with scale can pressure margins if customers shift procurement toward lowest-cost alternatives for certain applications.
  • Supply chain and component constraints: engineered products depend on specific materials/components; disruptions can impact lead times and service levels.
  • Regulatory and product liability exposure (fire and safety-related categories): compliance requirements and warranty/service obligations can introduce cost volatility.
  • Acquisition integration execution: portfolio growth via acquisitions can create integration risks in manufacturing processes, procurement, and customer program continuity.

📊 Valuation & Market View

The market typically values industrial specialty platforms using EV/EBITDA and earnings durability metrics rather than pure revenue growth multiples. The valuation framework tends to place weight on:

  • Margin stability and evidence of operating leverage across cycles.
  • Cash conversion and working-capital management (especially during order and inventory fluctuations).
  • Quality of revenue mix: higher installed-base/aftermarket share often commands a better multiple due to reduced cyclicality.
  • Execution on new design-in programs and retention of qualified-supplier status.

Key valuation drivers are sustained profitability through engineered differentiation, credible aftermarket contribution, and successful integration that avoids dilution of margins and service levels.

🔍 Investment Takeaway

IDEX’s long-term investment case rests on engineered product platforms that embed into customer equipment architectures, creating high switching costs through qualification requirements and installed-base continuity. The company’s competitive positioning emphasizes reliability, compliance discipline, and application-specific performance—factors that are structurally more defensible than commodity-like industrial component supply. Upside potential is tied to continued design-in wins and aftermarket durability, while the principal risks relate to industrial cycle sensitivity, execution in engineering qualification, and integration discipline.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for IEX.

defenseworld.net2026-07-31

Amundi Sells 268,259 Shares of IDEX Corporation $IEX

Amundi trimmed its holdings in IDEX Corporation (NYSE: IEX) by 18.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,219,400 shares of the industrial products company's stock after selling 268,259 shares during the quarter. Amundi owned about

defenseworld.net2026-07-30

IDEX (NYSE:IEX) Sets New 52-Week High After Strong Earnings

IDEX Corporation (NYSE: IEX - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $232.55 and last traded at $239.8090, with a volume of 608 shares. The stock had previously closed at $224.65. The industrial products company reported

marketbeat.com2026-07-30

IDEX Q2 Earnings Call Highlights

IDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.

seekingalpha.com2026-07-29

IDEX Corporation (IEX) Q2 2026 Earnings Call Transcript

IDEX Corporation (IEX) Q2 2026 Earnings Call Transcript

zacks.com2026-07-29

IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises View

IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.

zacks.com2026-07-29

Compared to Estimates, Idex (IEX) Q2 Earnings: A Look at Key Metrics

The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com2026-07-29

Idex (IEX) Q2 Earnings and Revenues Top Estimates

Idex (IEX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $2.07 per share a year ago.

businesswire.com2026-07-29

IDEX Reports Second Quarter Results

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2026. “We are very pleased to see continued results momentum as our IDEX teams drove another quarter of strong sales and earnings growth. Orders of over $1 billion in the quarter were a record as we continue to see elevated demand across the advantaged markets where we've focused our investments and capabilities,” said Eric D. Ashleman, IDEX Corporation.

zacks.com2026-07-27

IDEX Gears Up to Report Q2 Earnings: What's in the Cards?

IEX reports Q2 results on July 29, with revenue growth expected as Health & Science demand and acquisitions support sales despite cost pressures.

defenseworld.net2026-07-26

Analysts Set IDEX Corporation (NYSE:IEX) PT at $244.00

Shares of IDEX Corporation (NYSE: IEX - Get Free Report) have earned an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1

zacks.com2026-07-22

Idex (IEX) Earnings Expected to Grow: Should You Buy?

Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

defenseworld.net2026-07-22

IDEX Corporation $IEX Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System cut its holdings in shares of IDEX Corporation (NYSE: IEX) by 6.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 154,528 shares of the industrial products company's stock after selling 11,067 shares during the quarter.

defenseworld.net2026-07-22

Bank of New York Mellon Corp Decreases Stock Holdings in IDEX Corporation $IEX

Bank of New York Mellon Corp cut its holdings in IDEX Corporation (NYSE: IEX) by 16.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 406,486 shares of the industrial products company's stock after selling 81,622 shares during the quarter.

defenseworld.net2026-07-21

Fifth Third Bancorp Buys 12,680 Shares of IDEX Corporation $IEX

Fifth Third Bancorp grew its position in IDEX Corporation (NYSE: IEX) by 400.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,849 shares of the industrial products company's stock after acquiring an additional 12,680 shares during the quarter. Fifth Third Bancorp's

seekingalpha.com2026-07-17

Dividend Champion, Contender, And Challenger Highlights: Week Of July 19

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"IEX reported Q2’26 revenue of $920.6M and net income of $143.4M (EPS $1.94). QoQ revenue increased 3.79% ($886.9M → $920.6M) and net income rose 19.50% ($120.0M → $143.4M). YoY, revenue declined 6.33% ($865.4M in Q2’25 → $920.6M in Q2’26), while net income increased 9.00% ($131.6M in Q2’25 → $143.4M in Q2’26), indicating improved cost discipline and operating leverage. Profitability improved over the quarter and across the 4-quarter strip: gross margin expanded to 46.36% from 44.89% in Q1, and net margin rose to 15.58% from 13.53%. Operating and pre-tax margins also moved higher, consistent with stronger earnings despite softer YoY top-line. Cash flow quality was solid: operating cash flow was $200.0M and free cash flow $177.0M, with continued shareholder returns via buybacks ($77.1M) and dividends ($53.9M). Balance sheet resilience appears stable for a quasi-utility: total assets were $6.93B, up slightly QoQ, with equity roughly steady at $4.01B. Total shareholder returns are likely supported by strong momentum—price is up 25.5% YoY—while the current dividend yield is low (~0.32%). Valuation implies premium earnings multiples, so execution and sustained margin improvement matter for upside vs consensus targets."

Revenue Growth

Fair

QoQ revenue +3.79% (886.9M→920.6M). YoY revenue -6.33% (865.4M→920.6M comparison indicates decline vs prior-year Q2). Overall top-line trend is mixed.

Profitability

Good

Net margin improved to 15.58% (from 13.53% in Q1) and is up vs Q2’25 (15.21%). YoY net income +9.00% alongside higher QoQ earnings (+19.50%) suggests margin expansion/cost control.

Cash Flow Quality

Good

Q2’26 operating cash flow was $200.0M and free cash flow $177.0M. Continued cash returns via buybacks ($77.1M) and dividends ($53.9M). No cash stress indicated in the provided period.

Leverage & Balance Sheet

Positive

Total assets ~$6.93B and equity ~$4.01B are stable QoQ. Net debt is elevated at ~$1.24B but liquidity (cash & equivalents $621M) remains strong; debt level moved somewhat but resilience looks intact.

Shareholder Returns

Strong

Price momentum is strong: +25.50% over 1 year. Capital returns are also active (buybacks $77.1M and dividends $53.9M in Q2). Dividend yield is low (~0.32%), so total return is momentum/buyback-led.

Analyst Sentiment & Valuation

Neutral

Consensus price target of $247 vs current $205.92 implies ~20% upside to consensus, but valuation looks rich on earnings (P/E ~29x) with limited yield support; upside likely depends on continued margin delivery.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

So what: IDEX posted a strong Q2 with broad-based order growth (+28% organic) and clear margin expansion (+70 bps adjusted EBITDA margin to 28.1%), beating both EPS and guidance despite tariff-related complexity. The key driver was HST—orders +47% and margin strength (+270 bps YoY, excluding tariff dynamics still “high end” of guidance)—supported by data center, semiconductor, and space/defense end markets, plus operational execution and 8020. IEEPA tariff refunds provided a measurable tailwind (adjusted EBITDA +130 bps; EPS +$0.08) while simultaneously depressing organic growth by ~2% through customer rebates. The market read-through is constructive: management sees demand forming across both direct longer-lead commitments and shorter-cycle distribution activity, with July continuing the improved cadence. Guidance was raised across growth (5%–6% organic), EBITDA margin (27.0%–27.3%), EPS ($8.70–$8.85), and CapEx (~$110M), while reiterating that most of the portfolio still runs on rapid replenishment and will be monitored through Q3/Q4.

AI IconGrowth Catalysts

  • HST order growth +47% driven by data center, semiconductor, and space/defense demand; Performance Pneumatics primary/standby power and liquid-cooling flow control wins
  • Mott filtration business ramping within HST semiconductor portfolio, with ~50% recurring revenues in that semicon sub-portfolio
  • Water platform momentum in FMT (IDEX Intelligent Water) delivering municipal wastewater management analytics and increased demand
  • Record FMT orders over $1B supported by throughput improvements, supply chain readiness, higher staffing, and select capacity expansions

Business Development

  • BAND-IT: significant blanket order in aerospace/defense (noted as a key aerospace bellwether)
  • Mott filtration expansion driving ~50% recurring revenues within HST semiconductor portfolio (implies ongoing build-out/scale of filtration franchise)
  • Envirosight acquisition referenced as providing breadth in the water platform (municipal storm water/wastewater inspection tools and related equipment/cameras)

AI IconFinancial Highlights

  • Organic sales +5% vs guidance range; exceeded Q2 guidance with adjusted EPS $2.32 materially above guided $2.07–$2.12
  • Adjusted EBITDA margin expanded +70 bps YoY to 28.1%; adjusted gross margin expanded +110 bps to 46.4%
  • Orders grew +28% organically; HST orders +47%, FMT orders +11%, FSDP orders +19%
  • IEEPA tariff refunds: net benefit to Q2 adjusted EPS of +$0.08; reported adjusted EBITDA margin benefit +130 bps; consolidated organic growth reduced by ~2% due to expected customer rebates
  • HST margin flow-through ~40% YoY excluding tariff refunds; HST adjusted EBITDA margin expanded +270 bps YoY with rebates: tariff rebates reduced organic growth by 2% and were +90 bps to adjusted EBITDA margin
  • FMT adjusted EBITDA margin -20 bps YoY; tariff refunds benefited margin +180 bps; underlying margin in line with expectations
  • FSDP adjusted EBITDA margin -50 bps YoY; tariff refunds benefited margin +120 bps

AI IconCapital Funding

  • Free cash flow: $177M in Q2 2026
  • Liquidity: >$1.1B at quarter end
  • Share repurchases: $77M in Q2; quarterly repurchase pace targeted ~ $75M through rest of 2026 (flex higher based on leverage/bolt-on M&A/8020 decisions)
  • Dividends: $54M in Q2
  • Gross leverage improved from 2.1x a year ago to 1.9x

AI IconStrategy & Ops

  • 8020 operating system implementation focused on newly acquired businesses to expand margin expansion potential into 2027 and beyond
  • Supply chain readiness and select capacity expansions to support highest-growth/high-return businesses
  • Use of 8020 to allocate resources to highest value opportunities; backlog-driven confidence in raising 2026 outlook

AI IconMarket Outlook

  • 2026 organic growth raised to 5%–6% from prior 3%–4%
  • 2026 adjusted EBITDA margin raised to 27.0%–27.3% from prior 26.5%–27.0%
  • 2026 adjusted EPS guidance raised to $8.70–$8.85 from prior $8.35–$8.55
  • 2026 Q3 guidance: organic growth 5%–7%, adjusted EBITDA margin 27%–27.5%, adjusted EPS $2.20–$2.25
  • 2026 CapEx forecast increased from $90M to ~ $110M for select investments and capacity expansions

AI IconRisks & Headwinds

  • Tariff rebate mechanics: customer rebates reduce sales growth (organic growth -2% in Q2) despite offsetting gross margin/EBITDA benefits
  • FSDP sales pressure from expected dispensing activity reduction and softer European rescue markets (partially offset by continued aerospace strength)
  • FMT underlying mix pressure led to -20 bps YoY EBITDA margin (even with tariff refund margin benefits +180 bps)
  • Industrial/distribution demand uncertainty tied to geopolitical concerns, rate direction, and higher inflation (analyst discussion indicated distributors and small business owners remain cautious)

Q&A: Analyst Interest

  • FMT order profile & convergence: Management explained end-market inflection was visible first in longer-lead, direct/OEM-related items (water, mining, ABEL, Viking data-center support) and later rotated toward smaller distribution-driven orders as Q2 ended and continued into July. They expect both longer-cycle and classic mixed business to support back-half growth, while noting industrial uncertainty persists.
  • Tariff refunds mechanics & margin/EPS translation: Management quantified IEEPA impacts across cost of sales reduction (+), net interest expense reduction (-), and customer rebates recorded as sales reductions (offsetting volume/growth). They stated the net Q2 adjusted EPS benefit was +$0.08 and the adjusted EBITDA margin benefit was +130 bps, with organic growth reduced by ~2%.
  • HST visibility & blanket-order implications for next year: Management emphasized rapid replenishment remains the bulk model, but growth platforms are building broader visibility. For HST, backlog momentum has been building ~1.5 years with an inflection at early 2026; they highlighted data center commitments positioning 2027 volume and referenced a large Pneumatics data-center chunk as evidence of forward demand support.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the IEX Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for IEX.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (IEX)

© 2026 Stock Market Info — IDEX Corporation (IEX) Financial Profile